A study to assess prostate cancer pain with the addition of custirsen Ascertain whether the investigational arm has a greater proportion of patients with durable pain palliation as compared to the control arm.

• Country None
• organs None
• Specialty None

A study to find out if being treated with docetaxel and custirsen (new experimental drug) can increase survival in patients with advanced or metastatic non-small cell lung cancer, compared to the treatment with docetaxel alone. The patients must have received one prior line of platinum-based systemic anticancer therapy To evaluate if the combination regimen of custirsen and docetaxel improves the Overall Survival (OS) of patients with advanced or metastatic (Stage IV) NSCLC who have received one prior line of platin...

• Country None
• organs None
• Specialty None

The trial is designed to determine the efficacy of OGX-427 Vs placebo in combination with Gemcitabine and Cisplatin in patients with Urinary tract cancer To ascertain whether there is evidence of longer survival relative to the control arm for three comparisons: 600 mg OGX-427 Arm to control Arm; 1000 mg OGX-427 Arm to control Arm; and pooled 600 mg an...

• Country None
• organs None
• Specialty None

OGX-427-02 : Essai de phase 2 randomisé, évaluant l’innocuité et l’efficacité de l’OGX-427 en combinaison avec une chimiothérapie standard par gemcitabine et cisplatine, chez des patients ayant un cancer avancé du tractus urinaire. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions] L’objectif de cet essai est d’évaluer l’innocuité et l’efficacité de l’OGX-427 en combinaison avec une chimiothérapie standard gemcitabine et cisplatine, chez des patients ayant un cancer avancé du tr...

• Country France
• organs Vessie, Appareil urinaire - autres
• Specialty Thérapies Ciblées, Chimiothérapie